No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or whites

Saved in:

Bibliographic Details
Published in:	Cancer epidemiology, biomarkers & prevention Vol. 15; no. 1; pp. 175 - 177
Main Authors:	MILLIKAN, Robert C, HEARD, Kimberley, EDMISTON, Sharon, DE COTRET, Allan René, WINKEL, Scott, HILL, Edgar J, HEARD, Kristin, MASSA, Beri, MAYES, Lydia, WILLIAMS, Patricia, HOLSTON, Rachel, CONWAY, Kathleen
Format:	Journal Article
Language:	English
Published:	Philadelphia, PA American Association for Cancer Research 2006
Subjects:	African Americans - genetics Age of Onset Alleles Biological and medical sciences Breast Neoplasms - ethnology Breast Neoplasms - genetics Case-Control Studies European Continental Ancestry Group - genetics Female Gene Frequency Genes, p53 Genetic Predisposition to Disease Genotype Gynecology. Andrology. Obstetrics Humans Mammary gland diseases Medical sciences Mutation North Carolina Odds Ratio Polymorphism, Genetic Promoter Regions, Genetic Proto-Oncogene Proteins c-mdm2 - genetics Tumors United States North America America Human Genetic variability Transcription promoter Negroid Genotype Breast cancer Malignant tumor Epidemiology mdm2 Gene Mammary gland diseases Cancerology C-Onc gene Race Genetics Caucasoid Public health Protooncogene African American Polymorphism
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2
ISSN:	1055-9965 1538-7755
DOI:	10.1158/1055-9965.EPI-05-0692